- Home
- AUPH vs TUYA Comparison
AUPH vs TUYA Comparison
Compare AUPH & TUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- TUYA
- Stock Information
- Founded
- AUPH 1993
- TUYA 2014
- Country
- AUPH Canada
- TUYA China
- Employees
- AUPH N/A
- TUYA N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- TUYA Computer Software: Prepackaged Software
- Sector
- AUPH Health Care
- TUYA Technology
- Exchange
- AUPH Nasdaq
- TUYA Nasdaq
- Market Cap
- AUPH 1.4B
- TUYA 1.6B
- IPO Year
- AUPH 1999
- TUYA 2021
- Fundamental
- Price
- AUPH $12.81
- TUYA $2.61
- Analyst Decision
- AUPH Strong Buy
- TUYA Strong Buy
- Analyst Count
- AUPH 3
- TUYA 1
- Target Price
- AUPH $12.00
- TUYA $3.49
- AVG Volume (30 Days)
- AUPH 1.6M
- TUYA 2.0M
- Earning Date
- AUPH 11-06-2025
- TUYA 08-26-2025
- Dividend Yield
- AUPH N/A
- TUYA 4.15%
- EPS Growth
- AUPH N/A
- TUYA N/A
- EPS
- AUPH 0.42
- TUYA 0.05
- Revenue
- AUPH $260,111,000.00
- TUYA $318,493,000.00
- Revenue This Year
- AUPH $16.92
- TUYA $11.71
- Revenue Next Year
- AUPH $14.43
- TUYA $12.86
- P/E Ratio
- AUPH $30.61
- TUYA $53.19
- Revenue Growth
- AUPH 25.59
- TUYA 22.29
- 52 Week Low
- AUPH $6.43
- TUYA $1.28
- 52 Week High
- AUPH $12.90
- TUYA $4.63
- Technical
- Relative Strength Index (RSI)
- AUPH 68.86
- TUYA 54.33
- Support Level
- AUPH $12.06
- TUYA $2.46
- Resistance Level
- AUPH $12.82
- TUYA $2.73
- Average True Range (ATR)
- AUPH 0.37
- TUYA 0.13
- MACD
- AUPH -0.04
- TUYA 0.00
- Stochastic Oscillator
- AUPH 93.23
- TUYA 34.52
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About TUYA Tuya Inc. each representing one
Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.